Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/jphp.12581 http://scihub22266oqcxt.onion/10.1111/jphp.12581 C5396330!5396330!27334565     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Pharm+Pharmacol 2017 ; 69 (4): 432-8 Nephropedia Template TP {{tp|p=27334565|t=2017. Off?label and unlicensed medicines to hospitalised children in Norway |pdf=|usr=}}{{27334565}} gab.com Text Off label and unlicensed medicines to hospitalised children in Norway JO: J Pharm Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=27334565 #FOAvip Objectives: The aim of this study was to investigate the use of off?label (OL) and unlicensed (UL) medicines to hospitalised children in Norway, to add to the current knowledge on use of medicines in this vulnerable patient group. Methods: The study was performed as a cross?sectional prospective study. Medication was classified as on? or off?label based on the comparison with the SmPC regarding age, indication, dosage, route of administration and handling of the product. UL products were classified as imported or pharmacy produced. Key findings: More than 90% of children receiving medicines in our study were given OL or UL medicines. More patients received OL (83%) than UL (59%). Route of administration was the most frequently observed OL category. The vast majority of the OL prescriptions were for ?off?patent? products. One?third of products prescribed were UL. Conclusions: The study confirms that medicines to children in hospital to a significant degree are being used outside or without authorisation, in spite of recent paediatric regulatory initiatives. More data are still needed on efficacy and safety of medicines used in children, data to be incorporated in the SmPC. In addition, suitable formulations are needed to ensure optimal dosing and adherence without risky manipulations. Twit Text FOAVip Off label and unlicensed medicines to hospitalised children in Norway ????J Pharm Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=27334565 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27334565 #FOAvip English Wikipedia <ref>{{Cite pmid|27334565}}</ref> Off?label and unlicensed medicines to hospitalised children in Norway #MMPMID27334565 Teigen A; Wang S; Truong BT; Bjerknes K J Pharm Pharmacol 2017[Apr]; 69 (4): 432-8 PMID27334565show ga Objectives: The aim of this study was to investigate the use of off?label (OL) and unlicensed (UL) medicines to hospitalised children in Norway, to add to the current knowledge on use of medicines in this vulnerable patient group. Methods: The study was performed as a cross?sectional prospective study. Medication was classified as on? or off?label based on the comparison with the SmPC regarding age, indication, dosage, route of administration and handling of the product. UL products were classified as imported or pharmacy produced. Key findings: More than 90% of children receiving medicines in our study were given OL or UL medicines. More patients received OL (83%) than UL (59%). Route of administration was the most frequently observed OL category. The vast majority of the OL prescriptions were for ?off?patent? products. One?third of products prescribed were UL. Conclusions: The study confirms that medicines to children in hospital to a significant degree are being used outside or without authorisation, in spite of recent paediatric regulatory initiatives. More data are still needed on efficacy and safety of medicines used in children, data to be incorporated in the SmPC. In addition, suitable formulations are needed to ensure optimal dosing and adherence without risky manipulations. äOff?label and unlicensed medicines to hospitalised children in Norway (epmc).pdf DeepDyve Pubget Overpricing